Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT05130970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Garadacimab in Subjects With Idiopathic Pulmonary Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of garadacimab in subjects with idiopathic pulmonary fibrosis (IPF).
Study identification
- NCT ID
- NCT05130970
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2022
- Primary completion
- Jan 1, 2024
- Completion
- Jan 1, 2024
- Last update posted
- Dec 12, 2024
2022 – 2024
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35205 | — |
| Pulmonary Associates Clinical Trials AZ | Phoenix | Arizona | 85032 | — |
| National Institute of Clinical Research | Huntington Beach | California | 92647 | — |
| University of Southern California - Center for Advanced Lung Disease | Los Angeles | California | 90033 | — |
| University of California Irvine | Orange | California | 92868 | — |
| Meris Clinical Research | Brandon | Florida | 33511 | — |
| Reliant Medical Research | Miami | Florida | 33165 | — |
| US Associates in Research LLC | Miami | Florida | 33175 | — |
| Lakes Research | Miami Lakes | Florida | 33014 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Central Florida Pulmonary Group, PA | Orlando | Florida | 32803 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Jadestone Clinical Research | Silver Spring | Maryland | 20904 | — |
| Hannibal Clinic | Hannibal | Missouri | 63401 | — |
| Weill Cornell Medical Center | New York | New York | 10021 | — |
| Superior Clinical Research | Smithfield | North Carolina | 27577 | — |
| Southeastern Research Center | Winston-Salem | North Carolina | 27103 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Temple University TMS | Philadelphia | Pennsylvania | 19140 | — |
| Clinical Trial Center of Middle Tennesse | Franklin | Tennessee | 37067 | — |
| Elite Medical Research | Dallas | Texas | 75230 | — |
| Southwest Family Medicine Associates | Dallas | Texas | 75235 | — |
| Baylor Scott and White Health - Advanced Lung Disease Specialists | Dallas | Texas | 75246 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05130970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05130970 live on ClinicalTrials.gov.